Novo Nordisk A/S ADR buy stratec
Start price
26.10.18
/
50%
€37.88
Target price
09.01.19
€43.91
Performance (%)
16.33%
End price
09.01.19
€44.07
Summary
This prediction ended on 09.01.19 with a price of €44.07. The prediction had a final performance of 16.33%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 0.126% | 0.126% | -45.386% | -78.192% |
| iShares Core DAX® | 0.231% | -2.413% | 15.337% | 45.097% |
| iShares Nasdaq 100 | 1.663% | -1.658% | 31.087% | 76.365% |
| iShares Nikkei 225® | -0.208% | -2.502% | 43.625% | 49.585% |
| iShares S&P 500 | 1.067% | -1.579% | 24.346% | 57.069% |
Comments by stratec for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
stratec stimmt der Buy-Einschätzung von waltaurus zu
stratec stimmt am 26.10.2018 der Buy-Einschätzung von waltaurus mit dem Kursziel 48,68€ zu.
Überschrift: Novo Nordisk Insulin fürs Depot
(Vom Mitglied beendet)